Breaks Categories: News

ThursdayFeb 29, 2024 10:19 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN), Subsidiary Report Positive Clinical Results of CNM-Au8 Treatment at MS Forum

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., is reporting on the full clinical results for CNM-Au8(R), an investigational first-in-class therapy designed to improve central nervous system cells’ survival and function. Clene, which is focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), presented the results at the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum in Florida. The results were gathered from the VISIONARY-MS trial long-term open label extension (“LTE”) in participants with stable…

Continue Reading

ThursdayFeb 29, 2024 10:00 am

NetworkNewsBreaks – Ocean Biomedical Inc.’s (NASDAQ: OCEA) Joint Venture Partner to Present First Clinical Study Data at 33rd Annual Meeting of APASL

Ocean Biomedical (NASDAQ: OCEA), a biopharma company that endeavors to accelerate the development of compelling discoveries from top research scientists, congratulates its joint venture partner, Virion Therapeutics, LLC, a clinical-stage biotechnology company developing T cell-based immunotherapies, for the acceptance of its abstract highlighting the first-ever human data from its novel checkpoint modifier immunotherapy for HBV functional cure. The abstract was accepted for late breaker oral presentation at the 33rd Annual Meeting of APASL (The Asian Pacific Association for the Study of the Liver), taking place in Kyoto, Japan, from March 27-31, 2024. “This accepted abstract highlights Virion’s commitment to finding…

Continue Reading

ThursdayFeb 29, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Participate at Upcoming Sixth International Congress on Controversies in Fibromyalgia

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, will be featured at the upcoming Sixth International Congress on Controversies in Fibromyalgia. The event is scheduled for March 7, 2024, in Brussels, Belgium. During the one-day event, Tonix Pharmaceuticals CEO Seth Lederman, MD, is slated to present. During his presentation, Lederman will provide an overview of data from the recently reported positive phase 3 RESILIENT trial of Tonmya(TM) (also known as TNX-102 SL) for the management of fibromyalgia. To view the full press release, visit https://nnw.fm/s110j About Tonix Pharmaceuticals Holding Corp. Tonix is…

Continue Reading

WednesdayFeb 28, 2024 2:59 pm

NetworkNewsBreaks – Acri Capital Acquisition Corporation (NASDAQ: ACACU), Foxx Development Inc. Enter Business Combination Agreement

Acri Capital (NASDAQ: ACAC, ACACU, ACACW), a Delaware incorporated special purpose acquisition company listed on the Nasdaq Global Market, and Foxx Development Inc., a Texas-based consumer electronics and integrated Internet-of-Things (“IoT”) solution company, have announced their entry into a definitive business combination agreement. Under the agreement, a newly established subsidiary of Acri will become a publicly listed company combining Acri and Foxx (the “combined company”) upon the closing of the transaction, with expected listing of its common stock on the Nasdaq. “Acri’s inception revolved around the goal of identifying and partnering with companies led by visionary, mission-oriented leadership teams who…

Continue Reading

WednesdayFeb 28, 2024 2:49 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Announces Strategic Appointment of Garrett Gardi

HealthLynked (OTCQB: HLYK), a leader in health care technology solutions for patients and providers, has announced the addition of Garrett Gardi to its advisory board. Gardi has more than two decades of experience in employee benefit plans, specializing in predictive cost analytics, consumer-driven platforms, and self-funded/alternative funding methodologies, and brings a wealth of knowledge and expertise to the HealthLynked team. “Garrett’s addition to our advisory board marks a significant milestone for HealthLynked as we continue to expand our reach and impact in the health care sector,” said Dr. Michael Dent, CEO of HealthLynked. “His extensive experience and innovative approach to…

Continue Reading

WednesdayFeb 28, 2024 2:38 pm

NetworkNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Columbia-Based Subsidiary Names Agri-Tech Leader as Sales Director

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced that Eko2o S.A.S., a majority controlled subsidiary of MedCana in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, has appointed Paula Restrepo as its new sales director. With a career spanning over nine years as a technical representative for a prominent technology company in the Colombian flower industry, Restrepo brings a wealth of experience and a fresh perspective to the EKO2O team. Restrepo’s extensive background in agricultural technology and deep understanding of the Colombian market make her an invaluable asset. “We are thrilled to welcome Paula Restrepo to…

Continue Reading

WednesdayFeb 28, 2024 2:21 pm

NetworkNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Announces New Starter Course for Quantum Computing Programmers

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, has unveiled a six-module quantum training course designed for beginner quantum programmers. Called “Foundations for Quantum Programming,” the self-paced, online course teaches essential mathematics and Python skills and prepares individuals to continue on to successfully take D-Wave’s flagship course, “Quantum Programming Core.” The course includes video presentations, quizzes and hands-on programming activities that will assist students in learning to identify optimization problem objectives and variables, represent problem objectives as mathematical expressions, convert constraints to penalty functions…

Continue Reading

WednesdayFeb 28, 2024 1:26 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Board of Directors Approves Debt Settlement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has announced a debt settlement. According to the announcement, the company’s board of directors approved the settlement of $637,650 owed to arm's length creditors through issuing 545,000 Class B subordinate voting shares in the capital of the corporation; the shares were issued at $1.17 per share. The board also approved the granting of 55,000 restricted share units (“RSUs”) to consultants of the company according to FSD Pharma’s equity incentive plan, with each RSU good for the acquisition of…

Continue Reading

WednesdayFeb 28, 2024 12:23 pm

NetworkNewsBreaks — Advanced Gold Exploration Inc. (CSE: AUEX) Announces New President

Advanced Gold Exploration (CSE: AUEX), has appointed Dr. Andrew Ramcharan, PhD, P.Eng., as president of the company; the appointment was effective beginning Feb. 15, 2024. The company noted that current president Jim Atkinson is resigning as president, although he remains as CEO and as a company director. Ramcharan brings a deep background in investor relations and corporate strategies to his new position, having completed more than 300 project evaluations globally on many commodities and proposed 40-plus investment strategies; he has also been involved in the completion of two major takeover transactions worth $800 million and $1.5 billion and has raised more…

Continue Reading

WednesdayFeb 28, 2024 12:20 pm

NetworkNewsBreaks — Diamond Lake Minerals Inc. (DLMI) Spotlighted in Latest NNA Broadcast Focused on Avrio Investment

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. According to the announcement, the broadcast covers news of Diamond Lake Minerals’ strategic investment in Avrio Worldwide, PBC, which is the parent of several companies that provide licensed digital financial market infrastructure and services across public, private and digital markets. DLMI’s investment in Avrio offers key opportunities and synergies across the DLMI network of companies for the tokenization of real-world-assets (“RWA”) on Avrio’s registered dFMI, noted an Avrio official. NNA is focused…

Continue Reading